[1] |
Wang CX, Belsito DV. Chronic actinic dermatitis revisited[J]. Dermatitis, 2020,31(1):68⁃74. doi: 10.1097/DER.00000000000 00531.
|
[2] |
李凌佳, 刘彤云, 何黎, 等. 慢性光化性皮炎173例临床与病理分析[J]. 中国皮肤性病学杂志, 2018,32(10):1147⁃1152. doi: 10.13735/j.cjdv.1001⁃7089.201710017.
|
[3] |
中华医学会皮肤性病学分会免疫学组, 中国医师协会皮肤科医师分会指南制定与规范委员会. 皮炎湿疹类疾病规范化诊断术语专家共识[J]. 中华皮肤科杂志, 2021,54(11):937⁃942. doi: 10.35541/cjd.20210578.
|
[4] |
Maghfour J, Mohney L, Lim HW, et al. Demographics and clinical presentations of 844 patients with light and dark skin types with polymorphous light eruption and chronic actinic dermatitis evaluated over 23 years[J]. Photodermatol Photoimmunol Photomed, 2023,39(2):93⁃99. doi: 10.1111/phpp.12863.
|
[5] |
Gu Q, Zhang Z, Yang J, et al. Chronic actinic dermatitis: a 5⁃year clinical analysis of 488 patients in China[J]. Photodermatol Photoimmunol Photomed, 2023,39(3):263⁃268. doi: 10.1111/phpp.12835.
|
[6] |
Norris PG, Hawk JL. Chronic actinic dermatitis. A unifying concept[J]. Arch Dermatol, 1990,126(3):376⁃378. doi: 10.1001/ archderm.126.3.376.
|
[7] |
陈教全, 梁碧华, 彭丽倩, 等. 330例慢性光化性皮炎患者紫外线最小红斑量测定[J]. 皮肤性病诊疗学杂志, 2021,28(2):105⁃109,113. doi: 10.3969/j.issn.1674⁃8468.2021.02.005.
|
[8] |
Lin N, Huang X, Ma C, et al. Clinical and pathological findings of chronic actinic dermatitis[J]. Photodermatol Photoimmunol Photomed, 2021,37(4):313⁃320. doi: 10.1111/phpp.12654.
|
[9] |
Tu Y, Wu W, Guo Y, et al. Upregulation of hsa⁃miR⁃31⁃3p induced by ultraviolet affects keratinocytes permeability barrier by targeting CLDN1[J]. Biochem Biophys Res Commun, 2020,532(4):626⁃632. doi: 10.1016/j.bbrc.2020.06.113.
|
[10] |
Tu Y, Wang L, Wang X, et al. LncRNA⁃WAKMAR2 regulates expression of CLDN1 to affect skin barrier through recruiting c⁃Fos[J]. Contact Dermatitis, 2023,88(3):188⁃200. doi: 10.1111/cod.14256.
|
[11] |
Holman DM, Berkowitz Z, Guy GP Jr, et al. The association between demographic and behavioral characteristics and sunburn among U.S. adults ⁃ National Health Interview Survey, 2010[J]. Prev Med, 2014,63:6⁃12. doi: 10.1016/j.ypmed.2014. 02.018.
|
[12] |
Holman DM, Ding H, Guy GP Jr, et al. Prevalence of sun protection use and sunburn and association of demographic and behaviorial characteristics with sunburn among US adults[J]. JAMA Dermatol, 2018,154(5):561⁃568. doi: 10.1001/jamadermatol. 2018.0028.
|
[13] |
何凡, 马彦云, 孔凡旗, 等. 上海地区常驻居民紫外线最小红斑量的影响因素分析[J]. 临床皮肤科杂志, 2021,50(1):8⁃11. doi: 10.16761/j.cnki.1000⁃4963.2021.01.003.
|
[14] |
任捷, 胡跃, 马莉, 等. 慢性光化性皮炎常见致敏药物成份分析[J]. 世界临床药物, 2019,40(9):637⁃641,648. doi: 10.13683/j.wph.2019.09.008.
|
[15] |
马冰砚, 董丽萍, 陆晓云, 等. 基于LC⁃MS非靶向代谢组学分析进展期白癜风血清代谢物差异[J]. 中国皮肤性病学杂志, 2023,37(6):652⁃656. doi: 10.13735/j.cjdv.1001⁃7089.20221 1114.
|
[16] |
郑艳, 尹光文. 特应性皮炎代谢组学的研究进展[J]. 皮肤科学通报, 2023,40(1):14⁃24.
|
[17] |
李倩, 张锡宝, 梁景耀. 转录组学、蛋白组学及代谢组学在皮肤领域的应用[J]. 皮肤性病诊疗学杂志, 2022,29(1):77⁃81. doi: 10.3969/j.issn.1674⁃8468.2022.01.018.
|
[18] |
叶竹标, 张伟刚, 李春英, 等. 代谢组学及其在慢性炎症性皮肤病中的研究进展[J]. 临床皮肤科杂志, 2021,50(7):441⁃443. doi: 10.16761/j.cnki.1000⁃4963.2021.07.018.
|
[19] |
El Mahi Y, Varin A, Vetter M, et al. Resolved psoriasis with abundant oleic acid in stratum corneum exhibits lower T⁃cell⁃driven IL⁃17 signature[J/OL]. J Invest Dermatol, 2023,S0022⁃202X(23)02067⁃5. doi: 10.1016/j.jid.2023.04.021.
|
[20] |
Nordestgaard BG, Varbo A. Triglycerides and cardiovascular disease[J]. Lancet, 2014,384(9943):626⁃635. doi: 10.1016/S0140⁃6736(14)61177⁃6.
|
[21] |
Artunc F, Schleicher E, Weigert C, et al. The impact of insulin resistance on the kidney and vasculature[J]. Nat Rev Nephrol, 2016,12(12):721⁃737. doi: 10.1038/nrneph.2016.145.
|
[22] |
Yin H, Qiu Z, Zhu R, et al. Dysregulated lipidome of sebum in patients with atopic dermatitis[J]. Allergy, 2023,78(6):1524⁃1537. doi: 10.1111/all.15569.
|
[23] |
Díaz⁃Perales A, Escribese MM, Garrido⁃Arandia M, et al. The role of sphingolipids in allergic disorders[J]. Front Allergy, 2021,2:675557. doi: 10.3389/falgy.2021.675557.
|
[24] |
Li J, Li L, Liu R, et al. Integrative lipidomic features identify plasma lipid signatures in chronic urticaria[J]. Front Immunol, 2022,13:933312. doi: 10.3389/fimmu.2022.933312.
|
[25] |
Fu G, Guy CS, Chapman NM, et al. Metabolic control of TFH cells and humoral immunity by phosphatidylethanolamine[J]. Nature, 2021,595(7869):724⁃729. doi: 10.1038/s41586⁃021⁃03692⁃z.
|
[26] |
高芯, 李长印, 段徐彬, 等. 脂质组学在慢性肾病研究中的应用[J]. 药学进展, 2021,45(8):616⁃626.
|
[27] |
Nording H, Langer HF. Complement links platelets to innate immunity[J]. Semin Immunol, 2018,37:43⁃52. doi: 10.1016/j.smim.2018.01.003.
|
[28] |
Koenen RR. Lysophosphatidylcholine in platelet microvesicles: the grease for cardiovascular disease[J]. Thromb Haemost, 2019,119(8):1202⁃1204. doi: 10.1055/s⁃0039⁃1693024.
|
[29] |
王喆, 曲亮, 张金兰, 等. 基于靶向鞘脂组学和转录组学的雷公藤多苷片对迟发型超敏反应模型的量-效/毒机制初探[J]. 药学学报, 2018,53(11):1868⁃1878. doi: 10.16438/j.0513⁃4870.2018⁃0510.
|
[30] |
Russo MV, Tordoff J, Chiang SH, et al. Lipid dysregulation and antigen presentation during intestinal inflammation[J]. J Immunol, 2020,204(1_Supplement):217.18. doi: 10.4049/jimmunol.204.Supp.217.18.
|
[31] |
Saito K, Ueta M, Maekawa K, et al. Plasma lipid profiling of patients with chronic ocular complications caused by Stevens⁃Johnson syndrome/toxic epidermal necrolysis[J/OL]. PLoS One, 2016,11(11):e0167402. doi: 10.1371/journal.pone.0167402.
|
[32] |
Panov AV, Dikalov SI. Cardiolipin, perhydroxyl radicals, and lipid peroxidation in mitochondrial dysfunctions and aging[J]. Oxid Med Cell Longev, 2020,2020:1323028. doi: 10.1155/2020/1323028.
|